Castleark Management LLC Denali Therapeutics Inc. Transaction History

Castleark Management LLC

  • $2.41 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$25.97 - $38.53 $3.31 Million - $4.91 Million
127,460 New
127,460 $3.91 Million
Q4 2021

Feb 16, 2022
SELL
$42.59 - $55.02 $2.82 Million - $3.64 Million
-66,145 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$48.48 - $78.23 $1.8 Million - $2.9 Million
37,105 Added 127.77%
66,145 $3.34 Million
Q2 2021

Aug 17, 2021
BUY
$50.3 - $78.44 $1.46 Million - $2.28 Million
29,040 New
29,040 $2.28 Million

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email